Screening for metabolic dysfunction-associated steatotic liver disease in type 2 diabetes patients using the fibrosis-4 score in medina-retrospective study.
Almohammadi MA, Alsadi ZE, Alenezi AB, Ahmed FM, Ahmed BM, Mulla RM, Alrehaili NM, Alsaedi YA, Alhuwayfi AS, Surrati AM
The online reader was unable to display this document directly. This may occur if the repository host is temporarily unreachable, or if security restrictions (CORS) prevent embedded viewing.